Prevalence of abnormal echocardiographic findings in cancer patients: A retrospective evaluation of echocardiography for identifying cardiac abnormalities in cancer patients

Echocardiography

Volumn 28, Issue 10, 2011, Pages 1061-1067

  Daher, Iyad N ^a   Kim, Christopher ^b   Saleh, Ramy R ^c   Plana, Juan Carlos ^d   Yusuf, Syed Wamique ^a   Banchs, Jose ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cancer; echocardiography

Indexed keywords

AORTA VALVE DISEASE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIOMYOPATHY; DISEASE CLASSIFICATION; ECG ABNORMALITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART TUMOR; HUMAN; MEDICAL RECORD REVIEW; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SAFETY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; TRICUSPID VALVE DISEASE; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TEXAS; YOUNG ADULT;

EID: 81155133838     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2011.01490.x     Document Type: Review

References (31)

1. Altekruse SF KC, Krapcho M, Neyman N, et al,: SEER Cancer Statistics Review, 1975-2007, National Cancer Institute1975-2007: Available from:.
2. Clarke CA PD, Glaser SL,: Population attributable risk of breast cancer in white women with immediately modifiable risk factors. BMC Cancer 2006; 6: 170. Available at:.
3. Von Hoff DD LM, Basa P, Davis HL Jr, et al, Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 1979; 91 (5): 710-717. (Pubitemid 10218041)
4. Jones LW HM, Swartz JJ, Douglas PS, et al,: Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007; 50 (15): 1435-1441. (Pubitemid 47494586)
5. Hull M MC, Pepine C, Mendenhall N,: Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003; 290: 2831-2837. (Pubitemid 37509491)
6. Aleman BM vdB-DA, Klokman WJ, Van't Veer MB, et al,: Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21 (18): 3431-3439. (Pubitemid 46603515)
7. Ng AK BM, Weller E, Backstrand KH, et al,: Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20 (8): 2101-2108. (Pubitemid 34408801)
8. Aleman BM vdB-DA, De Bruin ML, van 't Veer MB, et al,: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007; 109 (5): 1878-1886. (Pubitemid 46348183)
9. Swerdlow AJ HC, Smith P, Cunningham D, et al,: Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst 2007; 99 (3): 206-214.
10. Taylor CW MP, Darby SC,: Cardiac risk factors of breast cancer radiotherapy: A contemporary review. Clin Oncol (R Coll Radiol) 2006; 18 (3): 236-246.
11. Doyle JJ NA, Jacobson JS, Grann VR, et al,: Chemotherapy and cardiotoxicity in older breast cancer patients: A population-based study. J Clin Oncol 2005; 23 (34): 8597-8605. (Pubitemid 46211501)
12. Yeh ET TA, Lenihan DJ, Yusuf SW, et al,: Cardiovascular complications of cancer therapy. Circulation 2004; 109 (25): 3122-3131.
13. Daher IN YE,: Vascular complications of selected cancer therapies. Nat Clin Practice Cardiovasc Med 2008; 12: 797-805.
14. Lund MB, Ihlen H, Voss BM, et al,: Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: An echocardiographic study. Heart 1996; 75: 591-595. (Pubitemid 26225030)
15. Hunt SA AW, Chin MH, Feldman AM, et al,: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation 2005; 112 (12): 154-235.
16. Douglas PS KB, Stainback RF, Weissman NJ, et al,: ACCF/ASE/ACEP/ASNC/ SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography. J Am Coll Cardiol 2007; 50 (2): 187-204.
17. Feigenbaum H AW, Ryan T,: Feigenbaum's Echocardiography, 6th Ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2005.
18. Plana JC,. Added value of real-time three-dimensional echocardiography in assessing cardiac masses. Curr Cardiol Rep 2009; 11: 205-209.
19. Hare JL BJ, Leano R, Jenkins C, et al,: Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 2009; 158 (2): 294-301.
20. International Statistical Classification of Diseases and Related Health Problems, 9th edition.
21. Kirkpatrick JN KB, Rahmouni HW, Chirinos JA, et al,: Application of appropriateness criteria in outpatient transthoracic echocardiography. J Am Soc Echocardiogr 2009; 22 (1): 53-59.
22. Rocco T DV, Fischman A, Straus HW,: Evaluation of ventricular function in patients with coronary artery disease. J Nucl Med 1989; 30: 1149-1165. (Pubitemid 19175973)
23. Godkar D BK, Bijal D, Megna R, et al,: Comparison and Co-relation of invasive and noninvasive methods of ejection fraction measurement. J Natl Med Assoc 2007; 99 (11): 1227-1234. (Pubitemid 350246904)
24. Oguz D OR, Gucuyener K, Acikgoz GV, et al,: A comparison between MUGA and echocardiography in patients with muscular dystrophy in the early detection of cardiac involvement. Pediatr Cardiol 1998; 19 (2): 150-154. (Pubitemid 28092881)
25. Galderisi M MF, Esposito R, Lomoriello VS, et al,: Cancer therapy and cardiotoxicity: The need of serial Doppler echocardiography. Cardiovasc Ultrasound 2007; 5 (4): doi:.
26. Sun V BT, Piper B, Koczywas M, et al,: Barriers to pain assessment and management in cancer survivorship. J Cancer Surviv 2008; 2 (1): 65-71.
27. Passik S DW, McDonald M, Rosenfeld B, et al,: Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998; 16 (4): 1594-1600. (Pubitemid 28175786)
28. Lloyd-Williams M FT, Rudd N,: A survey of antidepressant prescribing in the terminally ill. Palliative Med 1999; 13 (3): 234-238.
29. Berard RM BF, Viljoen G,: Depressive disorders in an out-patient oncology setting: Prevalence, assessment, and management. Psychooncology 1998; 7 (2): 112-120. (Pubitemid 28197880)
30. Perez EA SV, Davidson NE, Kaufman PA, et al,: Effect of doxorubicin plus cyclophosphamide on left ventricular ejection fraction in patients with breast cancer in the North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol 2004; 22 (18): 3700-3704. (Pubitemid 41095209)
31. Guarneri V LD, Valero V, Durand JB, et al,: Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: The M.D. Anderson Cancer Center experience. J Clin Oncol 2006; 24 (25): 4107-4115. (Pubitemid 46622286)